Health Watch Home
   
Health Care Value
 
Transparency Costs
 
Transparency Quallity
 
Health Care Competition
 
Freedom of Information
  
Editorials
 
Publications
 
Presentation
     
  Report an Incident
  Join Health Watch
 Search Health Watch
 
Subscribe to Health Watch USA's Newsletter
 

To contact Health Watch USA please  use the following E-Mail Address


Content in this website may be linked to, as long as the linking webpage and passage has a known and clearly stated author.

  

Commentary:  If You Are Immunocompromised, Do Not Despair, Plan and Prepare for Medical Care.
 

View OpEd:    https://www.infectioncontroltoday.com/view/if-you-are-immunocompromised-do-not-despair-plan-and-prepare-for-medical-care
   

References:         
       
1. Evans RA, Dube S, Lu Y, et al. Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study [published correction appears in Lancet Reg Health Eur. 2024 Jul 25;44:101008. doi: 10.1016/j.lanepe.2024.101008]. Lancet Reg Health Eur. 2023;35:100747. Published 2023 Oct 13. doi:10.1016/j.lanepe.2023.100747 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730312/
 
2. Bazant MZ, Bush JWM. A guideline to limit indoor airborne transmission of COVID-19. Proc Natl Acad Sci U S A. 2021;118(17):e2018995118. doi:10.1073/pnas.2018995118 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092463/
 
3. Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973-1987. doi:10.1016/S0140-6736(20)31142-9 https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(20)31142-9
 
4. Getting to and Sustaining the Next Normal A Roadmap
for Living with COVID. The COlton. Colton Foundation and the COVID Collaborative and The Rockefeller Foundation's Pandemic Prevention Institute. March 2022. https://www.rockefellerfoundation.org/wp-content/uploads/2022/03/Getting-to-and-Sustaining-the-Next-Normal-A-Roadmap-for-Living-with-Covid-Report-Final.pdf
 
5. Zhao D, Cheng S, Tsui FR, Mathur MB, Wang CJ. The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights: A Systematic Review. Int J Environ Res Public Health. 2024;21(6):654. Published 2024 May 21. doi:10.3390/ijerph21060654 https://www.mdpi.com/1660-4601/21/6/654
 
6. Carbon Dioxide. NASA. July 2024. https://climate.nasa.gov/vital-signs/carbon-dioxide/?intent=121
 
7. Indoor Carbon Dioxide Concentrations and Sick Building Syndrome Symptoms in the Base Study Revisited: Analysis of the 100 Building Dataset. Proceedings: Indoor Air 2002. Indoor Environment Dept., Lawrence Berkeley National Laboratory, Berkeley, CA, USA. https://www.epa.gov/sites/default/files/2014-08/documents/base_3c2o2.pdf
 
8. Kavanagh KT. Commentary: Charleston airport needs to improve its air quality. Post and Courier. Oct. 31, 2024. https://www.postandcourier.com/opinion/commentary/commentary-charleston-airport-needs-to-improve-its-air-quality/article_efafa202-74b6-11ee-8b7c-cb511e38e4fc.html
 
9. COVID-19. Ventilation in Buildings. CDC. May 12, 2023. https://www.cdc.gov/coronavirus/2019-ncov/community/ventilation.html
 
10. DeCuir J, Payne AB, Self WH, et al. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024. MMWR Morb Mortal Wkly Rep. 2024;73(8):180-188. Published 2024 Feb 29. doi:10.15585/mmwr.mm7308a5 https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a5.htm
 
11. Fact Sheet for Healthcare Providers: Emergency Use Authorization of Pemgarda. (Pemivibart) https://www.fda.gov/media/177067/download
 
12. Ernst D. Data Show COVID-19 PrEP Pemgarda Effective Against KP.3.1.1 Variant. Clinical Advisor. Oct. 1, 2024. https://www.clinicaladvisor.com/news/data-show-covid-19-prep-pemgarda-effective-against-kp-3-1-1-variant/